Safety and Efficacy of Catheter Ablation of Idiopathic Ventricular Arrhythmias Arising From Cardiac Outflow Tracts - Trial NCT03258112
Access comprehensive clinical trial information for NCT03258112 through Pure Global AI's free database. This phase not specified trial is sponsored by Assiut University and is currently Withdrawn. The study focuses on Ventricular Arrythmia. Target enrollment is 0 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Assiut University
Timeline & Enrollment
N/A
Mar 01, 2017
Nov 01, 2021
Primary Outcome
procedural success
Summary
Ventricular arrhythmias arising from cardiac outflow tract affect quality of life and can
 cause decrease in left ventricular ejection fraction.
 
 Drugs used for treating those arrhytmias may be ineffective or may have side effects.
 
 Radiofrequency catheter ablation can be used safely for treatment of outflow tract
 arrhythmias.
 
 There are different sites where those ventricular arrhythmias may originates, each site has
 different electrocardiographic characteristics, different procedural success rates and
 challenges in localization and ablation.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT03258112
Non-Device Trial